Effect of azithromycin on Prevotella intermedia lipopolysaccharide-induced production of interleukin-6 in murine macrophages

European Journal of Pharmacology

Volumn 729, Issue , 2014, Pages 10-16

  Choi, Eun Young ^a   Jin, Ji Young ^a   Choi, Jeom Il ^b,c   Choi, In Soon ^a   Kim, Sung Jo ^b,c  

^a Silla University   (South Korea)

^b Pusan National University   (South Korea)

^c Pusan National University Hospital   (South Korea)

Author keywords

Azithromycin; Interleukin 6; Lipopolysaccharide; NF B; SOCS1; STAT

Indexed keywords

AZITHROMYCIN; I KAPPA B KINASE ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; STAT1 PROTEIN; STAT3 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; SUPPRESSOR OF CYTOKINE SIGNALING 1; ANTIINFECTIVE AGENT; INTERLEUKIN-6, MOUSE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA BINDING; DRUG MECHANISM; ENZYME ACTIVATION; GENE EXPRESSION; MACROPHAGE; MOUSE; NONHUMAN; PREVOTELLA INTERMEDIA; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; RAW 264.7 CELL LINE; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CELL LINE; DOSE RESPONSE; DRUG EFFECTS; METABOLISM; MICROBIOLOGY; TOXICITY; TREATMENT OUTCOME;

ANIMALS; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; PREVOTELLA INTERMEDIA; TREATMENT OUTCOME;

EID: 84894551442     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2014.02.008     Document Type: Article

References (60)

1. Alexander, W.S., Suppressors of cytokine signalling (SOCS) in the immune system. Nat. Rev. Immunol. 2 (2002), 410–416.
2. Alexander, W.S., Hilton, D.J., The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immune response. Annu. Rev. Immunol. 22 (2004), 503–529.
3. Baeuerle, P.A., Henkel, T., Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12 (1994), 141–179.
4. Baker, P.J., Dixon, M., Evans, R.T., Dufour, L., Johnson, E., Roopenian, D.C., CD4+T cells and the proinflammatory cytokines gamma interferon and interleukin-6 contribute to alveolar bone loss in mice. Infect. Immun. 67 (1999), 2804–2809.
5. Braga, R.R., Carvalho, M.A., Bruña-Romero, O., Teixeira, R.E., Costa, J.E., Mendes, E.N., Farias, L.M., Magalhães, P.P., Quantification of five putative periodontal pathogens in female patients with and without chronic periodontitis by real-time polymerase chain reaction. Anaerobe 16 (2010), 234–239.
6. Cassatella, M.A., Gasperini, S., Bovolenta, C., Calzetti, F., Vollebregt, M., Scapini, P., Marchi, M., Suzuki, R., Suzuki, A., Yoshimura, A., Interleukin-10 (IL-10) selectively enhances CIS3/SOCS3 mRNA expression in human neutrophils: evidence for an IL-10-induced pathway that is independent of STAT protein activation. Blood 94 (1999), 2880–2889.
7. Choi, E.Y., Jin, J.Y., Lee, J.Y., Choi, J.I., Choi, I.S., Kim, S.J., Melatonin inhibits Prevotella intermedia lipopolysaccharide-induced production of nitric oxide and interleukin-6 in murine macrophages by suppressing NF-κB and STAT1 activity. J. Pineal. Res. 50 (2011), 197–206.
8. Chung, C.P., Nisengard, R.J., Slots, J., Genco, R.J., Bacterial IgG and IgM antibody titers in acute necrotizing ulcerative gingivitis. J. Periodontol. 54 (1983), 557–562.
9. Covert, M.W., Leung, T.H., Gaston, J.E., Baltimore, D., Achieving stability of lipopolysaccharide-induced NF-κB activation. Science 309 (2005), 1854–1857.
10. Culić, O., Eraković, V., Parnham, M.J., Anti-inflammatory effects of macrolide antibiotics. Eur. J. Pharmacol. 429 (2001), 209–229.
11. de Souza, J.A., Nogueira, A.V., de Souza, P.P., Cirelli, J.A., Garlet, G.P., Rossa, C. Jr., Expression of suppressor of cytokine signaling 1 and 3 in ligature-induced periodontitis in rats. Arch. Oral Biol. 56 (2011), 1120–1128.
12. Egan, P.J., Lawlor, K.E., Alexander, W.S., Wicks, I.P., Suppressor of cytokine signaling-1 regulates acute inflammatory arthritis and T cell activation. J. Clin. Invest. 111 (2003), 915–924.
13. Emingil, G., Han, B., Ozdemir, G., Tervahartiala, T., Vural, C., Atilla, G., Baylas, H., Sorsa, T., Effect of azithromycin, as an adjunct to nonsurgical periodontal treatment, on microbiological parameters and gingival crevicular fluid biomarkers in generalized aggressive periodontitis. J. Periodontal Res 47 (2012), 729–739.
14. Estrela, C.R., Pimenta, F.C., Alencar, A.H., Ruiz, L.F., Estrela, C., Detection of selected bacterial species in intraoral sites of patients with chronic periodontitis using multiplex polymerase chain reaction. J. Appl. Oral Sci 18 (2010), 426–431.
15. Gao, J.J., Filla, M.B., Fultz, M.J., Vogel, S.N., Russell, S.W., Murphy, W.J., Autocrine/paracrine IFN-αβ mediates the lipopolysaccharide-induced activation of transcription factor Stat1α in mouse macrophages: pivotal role of Stat1α in induction of the inducible nitric oxide synthase gene. J. Immunol. 161 (1998), 4803–4810.
16. Garlet, G.P., Cardoso, C.R., Campanelli, A.P., Martins, W. Jr., Silva, J.S., Expression of suppressors of cytokine signaling in diseased periodontal tissues: a stop signal for disease progression?. J. Periodontal Res. 41 (2006), 580–584.
17. Geivelis, M., Turner, D.W., Pederson, E.D., Lamberts, B.L., Measurements of interleukin-6 in gingival crevicular fluid from adults with destructive periodontal disease. J. Periodontol. 64 (1993), 980–983.
18. Ghosh, S., May, M.J., Kopp, E.B., NF-κB and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16 (1998), 225–260.
19. Gingras, S., Parganas, E., de Pauw, A., Ihle, J.N., Murray, P.J., Re-examination of the role of suppressor of cytokine signaling 1 (SOCS1) in the regulation of toll-like receptor signaling. J. Biol. Chem. 279 (2004), 54702–54707.
20. Hamada, S., Takada, H., Ogawa, T., Fujiwara, T., Mihara, J., Lipopolysaccharides of oral anaerobes associated with chronic inflammation: chemical and immunomodulating properties. Int. Rev. Immunol. 6 (1990), 247–261.
21. Hayden, M.S., Ghosh, S., Signaling to NF-κB. Genes Dev. 18 (2004), 2195–2224.
22. Hirsch, R., Deng, H., Laohachai, M.N., Azithromycin in periodontal treatment: more than an antibiotic. J. Periodontal Res 47 (2012), 137–148.
23. Hoepelman, I.M., Schneider, M.M., Azithromycin: the first of the tissue-selective azalides. Int. J. Antimicrob. Agents 5 (1995), 145–167.
24. Karin, M., Ben-Neriah, Y., Phosphorylation meets ubiquitination: the control of NF-κB activity. Annu. Rev. Immunol. 18 (2000), 621–663.
25. Kim, S.J., Ha, M.S., Choi, E.Y., Choi, J.I., Choi, I.S., Prevotella intermedia lipopolysaccharide stimulates release of nitric oxide by inducing expression of inducible nitric oxide synthase. J. Periodontal Res 39 (2004), 424–431.
26. Kim, S.J., Choi, E.Y., Kim, E.G., Shin, S.H., Lee, J.Y., Choi, J.I., Choi, I.S., Prevotella intermedia lipopolysaccharide stimulates release of tumor necrosis factor-alpha through mitogen-activated protein kinase signaling pathways in monocyte-derived macrophages. FEMS Immunol. Med. Microbiol. 51 (2007), 407–413.
27. Kinjyo, I., Hanada, T., Inagaki-Ohara, K., Mori, H., Aki, D., Ohishi, M., Yoshida, H., Kubo, M., Yoshimura, A., SOCS1/JAB is a negative regulator of LPS-induced macrophage activation. Immunity 17 (2002), 583–591.
28. Kirikae, T., Nitta, T., Kirikae, F., Suda, Y., Kusumoto, S., Qureshi, N., Nakano, M., Lipopolysaccharides (LPS) of oral black-pigmented bacteria induce tumor necrosis factor production by LPS-refractory C3H/HeJ macrophages in a way different from that of Salmonella LPS. Infect. Immun 67 (1999), 1736–1742.
29. Kobayashi, K., Takahashi, N., Jimi, E., Udagawa, N., Takami, M., Kotake, S., Nakagawa, N., Kinosaki, M., Yamaguchi, K., Shima, N., Yasuda, H., Morinaga, T., Higashio, K., Martin, T.J., Suda, T., Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction. J. Exp. Med. 191 (2000), 275–286.
30. Kornman, K.S., Loesche, W.J., The subgingival microbial flora during pregnancy. J. Periodontal Res 15 (1980), 111–122.
31. Kubo, M., Hanada, T., Yoshimura, A., Suppressors of cytokine signaling and immunity. Nat. Immunol. 4 (2003), 1169–1176.
32. Li, Q., Verma, I.M., NF-κB regulation in the immune system. Nat. Rev. Immunol. 2 (2002), 725–734.
33. Liu, X.H., Kirschenbaum, A., Yao, S., Levine, A.C., Cross-talk between the interleukin-6 and prostaglandin E2signaling systems results in enhancement of osteoclastogenesis through effects on the osteoprotegerin/receptor activator of NF-κB (RANK) ligand/RANK system. Endocrinology 146 (2005), 1991–1998.
34. Matejka, M., Partyka, L., Ulm, C., Solar, P., Sinzinger, H., Nitric oxide synthesis is increased in periodontal disease. J. Periodontal Res 33 (1998), 517–518.
35. Meyer, M., Huaux, F., Gavilanes, X., van den Brûle, S., Lebecque, P., Lo, Re, S., Lison, D., Scholte, B., Wallemacq, P., Leal, T., Azithromycin reduces exaggerated cytokine production by M1 alveolar macrophages in cystic fibrosis. Am. J. Respir. Cell Mol. Biol. 41 (2009), 590–602.
36. Mogi, M., Otogoto, J., Ota, N., Inagaki, H., Minami, M., Kojima, K., Interleukin 1β, interleukin 6, β2-microglobulin, and transforming growth factor-α in gingival crevicular fluid from human periodontal disease. Arch. Oral Biol. 44 (1999), 535–539.
37. Morita, Y., Naka, T., Kawazoe, Y., Fujimoto, M., Narazaki, M., Nakagawa, R., Fukuyama, H., Nagata, S., Kishimoto, T., Signals transducers and activators of transcription (STAT)-induced STAT inhibitor-1 (SSI-1)/suppressor of cytokine signaling-1 (SOCS-1) suppresses tumor necrosis factor α-induced cell death in fibroblasts. Proc. Natl. Acad. Sci. U.S.A. 97 (2000), 5405–5410.
38. Morrison, D.C., Ryan, J.L., Endotoxins and disease mechanisms. Annu. Rev. Med. 38 (1987), 417–432.
39. Pelt, P., Zimmermann, B., Ulbrich, N., Bernimoulin, J.P., Effects of lipopolysaccharide extracted from Prevotella intermedia on bone formation and on the release of osteolytic mediators by fetal mouse osteoblasts in vitro. Arch. Oral Biol 47 (2002), 859–866.
40. Pfitzner, E., Kliem, S., Baus, D., Litterst, C.M., The role of STATs in inflammation and inflammatory diseases. Curr. Pharm. Des 10 (2004), 2839–2850.
41. Preshaw, P.M., Host response modulation in periodontics. Periodontol. 2000:48 (2008), 92–110.
42. Reddy, M.S., Geurs, N.C., Gunsolley, J.C., Periodontal host modulation with antiproteinase, anti-inflammatory, and bone-sparing agents. A systematic review. Ann. Periodontol 8 (2003), 12–37.
43. Retsema, J., Girard, A., Schelkly, W., Manousos, M., Anderson, M., Bright, G., Borovoy, R., Brennan, L., Mason, R., Spectrum and mode of action of azithyromycin (CP-62,993), a new 15-membered-ring macrolide with improved potency against gram-negative organisms. Antimicrob. Agents Chemother. 31 (1987), 1939–1947.
44. Rothwarf, D.M., Karin, M., The NF-κB activation pathway: a paradigm in information transfer from membrane to nucleus. Sci. STKE, 1999, 1999, RE1.
45. Rubin, B.K., Immunomodulatory properties of macrolides: overview and historical perspective. Am. J. Med 117 (2004), 2S–4S.
46. Samavati, L., Rastogi, R., Du, W., Hüttemann, M., Fite, A., Franchi, L., STAT3 tyrosine phosphorylation is critical for interleukin 1 beta and interleukin-6 production in response to lipopolysaccharide and live bacteria. Mol. Immunol. 46 (2009), 1867–1877.
47. Sampaio, E., Rocha, M., Figueiredo, L.C., Faveri, M., Duarte, P.M., Gomes Lira, E.A., Feres, M., Clinical and microbiological effects of azithromycin in the treatment of generalized chronic periodontitis: a randomized placebo-controlled clinical trial. J. Clin. Periodontol. 38 (2011), 838–846.
48. Schindler, C., Darnell, J.E. Jr., Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu. Rev. Biochem. 64 (1995), 621–651.
49. Schindler, C., Levy, D.E., Decker, T., JAK-STAT signaling: from interferons to cytokines. J. Biol. Chem. 282 (2007), 20059–20063.
50. Shinkai, M., Foster, G.H., Rubin, B.K., Macrolide antibiotics modulate ERK phosphorylation and IL-8 and GMCSF production by human bronchial epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol 290 (2006), L75–L85.
51. Starr, R., Willson, T.A., Viney, E.M., Murray, L.J., Rayner, J.R., Jenkins, B.J., Gonda, T.J., Alexander, W.S., Metcalf, D., Nicola, N.A., Hilton, D.J., A family of cytokine-inducible inhibitors of signalling. Nature 387 (1997), 917–921.
52. Stashenko, P., Jandinski, J.J., Fujiyoshi, P., Rynar, J., Socransky, S.S., Tissue levels of bone resorptive cytokines in periodontal disease. J. Periodontol. 62 (1991), 504–509.
53. Stoiber, D., Kovarik, P., Cohney, S., Johnston, J.A., Steinlein, P., Decker, T., Lipopolysaccharide induces in macrophages the synthesis of the suppressor of cytokine signaling 3 and suppresses signal transduction in response to the activating factor IFN-γ. J. Immunol 163 (1999), 2640–2647.
54. Suzaki, H., Asano, K., Ohki, S., Kanai, K., Mizutani, T., Hisamitsu, T., Suppressive activity of a macrolide antibiotic, roxithromycin, on proinflammatory cytokine production in vitro and in vivo. Mediators Inflamm. 8 (1999), 199–204.
55. Tamura, T., Udagawa, N., Takahashi, N., Miyaura, C., Tanaka, S., Yamada, Y., Koishihara, Y., Ohsugi, Y., Kumaki, K., Taga, T., Kishimoto, T., Suda, T., Soluble interleukin-6 receptor triggers osteoclast formation by interleukin-6. Proc. Natl. Acad. Sci. U.S.A. 90 (1993), 11924–11928.
56. Tatakis, D.N., Interleukin-1 and bone metabolism: a review. J. Periodontol. 64 (1993), 416–431.
57. Vanaudenaerde, B.M., Wuyts, W.A., Geudens, N., Dupont, L.J., Schoofs, K., Smeets, S., Van Raemdonck, D.E., Verleden, G.M., Macrolides inhibit IL17-induced IL8 and 8-isoprostane release from human airway smooth muscle cells. Am. J. Transplant. 7 (2007), 76–82.
58. Williams, R.C., Periodontal disease. N. Engl. J. Med. 322 (1990), 373–381.
59. Yamauchi, K., Shibata, Y., Kimura, T., Abe, S., Inoue, S., Osaka, D., Sato, M., Igarashi, A., Kubota, I., Azithromycin suppresses interleukin-12p40 expression in lipopolysaccharide and interferon-γ stimulated macrophages. Int. J. Biol. Sci. 5 (2009), 667–678.
60. Zuckerman, J.M., Qamar, F., Bono, B.R., Macrolides, ketolides, and glycylcyclines: azithromycin, clarithromycin, telithromycin, tigecycline. Infect. Dis. Clin. North Am. 23 (2009), 997–1026.